Trials / Active Not Recruiting
Active Not RecruitingNCT04968548
Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening
Determination and Validation of Lung EpiCheck®: A Multianalyte Assay for Lung Cancer Prediction. A Case-Control Study
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,000 (estimated)
- Sponsor
- Nucleix Ltd. · Industry
- Sex
- All
- Age
- 50 Years – 80 Years
- Healthy volunteers
- —
Summary
This study is part of the development and validation of a non-invasive lung screening test which aim to identify early stage lung cancer in patients at high risk for lung cancer.
Detailed description
This is a prospective, case-control, multi-center, observational nonsignificant risk study. The study aims to collect blood and clinical data from subjects undergoing Low Dose CT (LDCT) for lung cancer screening and subjects with confirmed lung cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Blood collection | Peripheral blood will be collected via routine venipuncture procedure |
Timeline
- Start date
- 2021-09-17
- Primary completion
- 2025-12-01
- Completion
- 2025-12-01
- First posted
- 2021-07-20
- Last updated
- 2025-11-04
Locations
31 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT04968548. Inclusion in this directory is not an endorsement.